✦ LIBER ✦

Ambiguous results of an attempt to withdraw barbiturates in epilepsy patients with intellectual disability

✍ Scribed by Bernd Huber; M. Bocchicchio; I. Hauser; V. Horstmann; G. Jokeit; T. May; T. Meinert; E. Robertson; H. Schorlemmer; L. Schulz; W. Wagner; M. Seidel

Book ID: 116880501
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 317 KB
Volume: 18
Category: Article
ISSN: 1059-1311
DOI: 10.1016/j.seizure.2008.07.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of pregabalin

Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability

✍ Bernd Huber; Michelina Bocchicchio; Elisabeth Feuerbaum; Theodor May; Thomas Mei 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Patterns of multimorbidity in an older p

Patterns of multimorbidity in an older population of persons with an intellectual disability: Results from the intellectual disability supplement to the Irish longitudinal study on aging (IDS-TILDA)

✍ McCarron, Mary; Swinburne, Janet; Burke, Eilish; McGlinchey, Eimear; Carroll, Ra 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Knowledge of results and learning to tel

Knowledge of results and learning to tell the time in an adult male with an intellectual disability: a single-subject research design

✍ Samantha L Applegate; Martin S Rice; Franklin Stein; Kinsuk K Maitra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract The present study investigated whether knowledge of results, in the form of visual and audible feedback, would increase the accuracy of time‐telling in an individual with an intellectual disability. A 19‐year‐old male with mild intellectual disability participated in this A1–B1–A2–B2 si

Molecular cytogenetic characterization o

Molecular cytogenetic characterization of an interstitial deletion of chromosome 21 (21q22.13q22.3) in a patient with dysmorphic features, intellectual disability and severe generalized epilepsy

✍ Angelo Valetto; Alessandro Orsini; Veronica Bertini; Benedetta Toschi; Alice Bon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 624 KB

Apremilast, an oral phosphodiesterase 4

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe psoriasis: Results from the randomized treatment withdrawal phase of a phase 3, randomized, controlled trial (ESTEEM 1)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

PND39 RESPONSIVENESS OF THE MULTIPLE SCL

PND39 RESPONSIVENESS OF THE MULTIPLE SCLEROSIS INTERNATIONAL QUALITY OF LIFE QUESTIONNAIRE TO EXPANDED DISABILITY STATUS SCALE SCORE CHANGES IN PATIENTS WITH MULTIPLE SCLEROSIS: MONTH 12 RESULTS FROM AN INTERNATIONAL OBSERVATIONAL STUDY

✍ P Auquier; O Fernandez; H Butzkueven; P Flachenecker; E Idiman; J Pelletier; S S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB